Uncategorized

Aethlon Medical to Initiate Hepatitis-C Trials; Clinical Programs in India to Be Managed in Conjunction with HIV/AIDS Studies

Aethlon Medical to Initiate Hepatitis-C Trials; Clinical Programs in India to Be Managed in Conjunction with HIV/AIDS Studies Aethlon Medical to Initiate Hepatitis-C Trials; Clinical Programs in India to Be Managed in Conjunction with HIV/AIDS Studies Wednesday, February 23, 2005 SAN DIEGO, Feb 23, 2005 – Aethlon Medical, Inc. (OTCBB: AEMD) announced today that it …

Aethlon Medical to Initiate Hepatitis-C Trials; Clinical Programs in India to Be Managed in Conjunction with HIV/AIDS Studies Read More »

Aethlon gets Industry and Government support in India for its forthcoming HIV/HCV trials

Aethlon gets Industry and Government support in India for its forthcoming HIV/HCV trials “Aethlon gets Industry and Government support in India for its forthcoming HIV/HCV trials”. Monday, March 28, 2005 Aethlon Receives Government and Industry Support for HIV and Hepatitis-C Trials in India SAN DIEGO–(BUSINESS WIRE)–March 28, 2005–Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it …

Aethlon gets Industry and Government support in India for its forthcoming HIV/HCV trials Read More »

Aethlon Medical Announces Hepatitis-C Clinical Trial Site

Aethlon Medical Announces Hepatitis-C Clinical Trial Site “Aethlon Medical Announces Hepatitis-C Clinical Trial Site”. Aethlon Medical Inc. (ticker: AEMD, exchange: OTC Bulletin Board (.OB)) News Release Thursday, June 9, 2005 SAN DIEGO–(BUSINESS WIRE)–June 9, 2005–Aethlon Medical, Inc. (OTCBB:AEMD) announced today that Qualtran LLC, a contract research organization (CRO) managing biocompatibility studies and clinical trials for …

Aethlon Medical Announces Hepatitis-C Clinical Trial Site Read More »

Chantest, the world leader in Ion Channel Research Signs Qualtran for Drug trial in India

Chantest, the world leader in Ion Channel Research Signs Qualtran for Drug trial in India “Chantest, the world leader in Ion Channel Research Signs Qualtran for Drug trial in India”. Cleveland (Business Wire), October 15, 2006 Cleveland, OH – October 15, 2006 – Qualtran, LLC. – a contract research organization (CRO) – announced today the …

Chantest, the world leader in Ion Channel Research Signs Qualtran for Drug trial in India Read More »

Qualtran to initiate In Vitro Studies at National Institute of Virology, India

Vitro Studies at National Institute of Virology Vitro Studies at National Institute of Virology Chicago (Business Wire), November 29, 2006 Qualtran has initiated the process of conducting In Vitro Studies using the Hemopurifier Cartridge developed by Aethlon Medical in India. These studies will be conducted at National Institute of Virology, India. NIV is the premier …

Qualtran to initiate In Vitro Studies at National Institute of Virology, India Read More »

Aethlon Medical Announces Dengue Virus Collaboration With Government of India Researchers

Aethlon Medical Announces Dengue Virus Collaboration With Government of India Researchers “Aethlon Medical Announces Dengue Virus Collaboration With Government of India Researchers”. SAN DIEGO (BUSINESS WIRE) – Dec. 5, 2006 Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has agreed to collaborate with researchers at the National Institute of Virology (NIV) to initiate testing its …

Aethlon Medical Announces Dengue Virus Collaboration With Government of India Researchers Read More »

Millennium Healthcare LLC, USA signs up with Qualtran for an HIV trail in India

Millennium Healthcare LLC, USA signs up with Qualtran for an HIV trail in India “Millennium Healthcare LLC, USA signs up with Qualtran for an HIV trail in India” Cleveland (Business Wire), February 15, 2007 Cleveland, OH – February 15, 2007 – Qualtran, LLC. – a contract research organization (CRO) specialized in medical devices – announced …

Millennium Healthcare LLC, USA signs up with Qualtran for an HIV trail in India Read More »

Qualtran successfully facilitates a multi-million licensing deal between DxTech and Nicholas Piramal

Qualtran successfully facilitates a multi-million licensing deal between DxTech and Nicholas Piramal “Qualtran successfully facilitates a multi-million licensing deal between DxTech and Nicholas Piramal” Business Wire, June 19, 2008 and PR Log, June 19, 2008 Qualtran, a CRO and Biotechnology consulting firm today announced that it has successfully consummated a license deal between DxTech LLC …

Qualtran successfully facilitates a multi-million licensing deal between DxTech and Nicholas Piramal Read More »

Qualtran facilitates an MOU between, PetroAlgae, USA and Indian Oil Corp

Qualtran facilitates an MOU between, PetroAlgae, USA and Indian Oil Corp Qualtran facilitates an MOU between, PetroAlgae, USA and Indian Oil Corp Wednesday, November 19, 2009 Qualtran, a Biotechnology and Technology Transfer Consulting firm from Cleveland, OH, announced today that it has successfully facilitated an MOU between PetroAlgae Inc. (OTCBB: PALG) (PetroAlgae or the Company) …

Qualtran facilitates an MOU between, PetroAlgae, USA and Indian Oil Corp Read More »